Overviews and analysis of the U.S. FDA′s new approvals in first half year of 2015 / 国际药学研究杂志
Journal of International Pharmaceutical Research
;
(6): 531-538, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-478513
ABSTRACT
In the first half year of 2015, the U.S. Food and Drug Administration(FDA) approved 11 new molecular entities and 5 new biologic license applications. According to the prescription information for professionals, this article introduces the description, mechanism of action and clinical studies; briefly describes the box warning, indications and usage, dosage and administration, dosage form and strength, contraindications, warning and precautions, adverse reactions, drug interaction and use in special population of these new drugs. In addition, the first and critical events in the history of new drug reaserch and development are emphasized.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Pharmaceutical Research
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS